NCT02204410View on ClinicalTrials.gov

Omega-3 Supplementation to ADHD Medication in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

August 31, 2016

Conditions
Attention Deficit Hyperactivity DisorderDeficient Emotional Self-Regulation
Interventions
DIETARY_SUPPLEMENT

Omega-3 Fatty Acid

DRUG

ADHD Medication

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT02204410 - Omega-3 Supplementation to ADHD Medication in Children | Biotech Hunter | Biotech Hunter